Health officials have confirmed the first detected case of a new strain of monkey pox (mpox) in the United States.
The clade I strain, which was first reported in the eastern Congo earlier this year, was found in a traveler who had returned from eastern Africa to northern California, the California Department of Public Health (CDPH) said on Saturday.
There is currently an ongoing outbreak of the new mpox strain in central and eastern Africa, spreading mostly through sexual transmission as well as through close contact among children, pregnant women, and other vulnerable groups.
Other countries to report cases of the clade I strain include Germany, Sweden, the United Kingdom, India, Thailand, Kenya, and Zimbabwe.
The clade I strain is distinct from the mpox clade II strain that spread earlier in 2022 and become a global outbreak. Gay men made up the vast majority of clade II cases.
Mpox is a rare disease caused by a virus from the same family as smallpox. Endemic in parts of Africa, people there have been infected through bites from rodents or small animals.
‘Very Low’ Risk
State health officials say the risk to U.S. public health from the returned traveler with the clade I strain is “very low.”According to the U.S. Centers for Disease Control and Prevention (CDC), “The individual was treated shortly after returning to the United States at a local medical facility and released,” and is now isolating at home in San Mateo County. The person’s symptoms are improving, health officials said, and health workers haven’t detected other cases within the person’s close contacts.
To date, there have been 3,100 confirmed cases of the strain, mostly in the three central African countries of the Democratic Republic of the Congo, Burundi, and Uganda, according to the World Health Organization. Reported cases spiked in late September.
Health officials said earlier this month that the situation in the Congo appears to be stabilizing.
Disease Severity
African outbreaks of clade I mpox were initially reported to be more severe than clade II, with death rates of around 3 to 11 percent. However, recent data indicates that when patients have access to good medical oversight and supportive clinical care, like in the United States, death rates are much lower at around 1 percent.“Current data supports that subclade Ib has a lower death rate of < 1 percent both in and outside of Africa,” the CDC said. The California cases has been identified as clade I, subclade Ib.
The virus has an incubation period of 3 to 17 days, during which a person does not have symptoms and feels fine.